LIMES SCHLOSSKLINIKEN AG (LIK.DE) Fundamental Analysis & Valuation

FRA:LIK • DE000A0JDBC7

Current stock price

490 EUR
-10 (-2%)
Last:

This LIK.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. LIK.DE Profitability Analysis

1.1 Basic Checks

  • LIK had positive earnings in the past year.
  • LIK had positive earnings in 4 of the past 5 years.
  • In multiple years LIK reported negative operating cash flow during the last 5 years.
LIK.DE Yearly Net Income VS EBIT VS OCF VS FCFLIK.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M

1.2 Ratios

  • The Return On Assets of LIK (10.51%) is better than 100.00% of its industry peers.
  • LIK's Return On Equity of 20.85% is amongst the best of the industry. LIK outperforms 100.00% of its industry peers.
  • LIK has a Return On Invested Capital of 15.26%. This is amongst the best in the industry. LIK outperforms 100.00% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for LIK is significantly above the industry average of 5.91%.
Industry RankSector Rank
ROA 10.51%
ROE 20.85%
ROIC 15.26%
ROA(3y)11.35%
ROA(5y)9.91%
ROE(3y)25.76%
ROE(5y)22.78%
ROIC(3y)15.32%
ROIC(5y)N/A
LIK.DE Yearly ROA, ROE, ROICLIK.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

1.3 Margins

  • Looking at the Profit Margin, with a value of 10.81%, LIK belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • LIK's Profit Margin has declined in the last couple of years.
  • LIK has a better Operating Margin (16.42%) than 100.00% of its industry peers.
  • In the last couple of years the Operating Margin of LIK has declined.
  • LIK has a better Gross Margin (95.03%) than 100.00% of its industry peers.
  • In the last couple of years the Gross Margin of LIK has remained more or less at the same level.
Industry RankSector Rank
OM 16.42%
PM (TTM) 10.81%
GM 95.03%
OM growth 3Y-14.42%
OM growth 5YN/A
PM growth 3Y-19.47%
PM growth 5YN/A
GM growth 3Y-0.09%
GM growth 5Y-0.06%
LIK.DE Yearly Profit, Operating, Gross MarginsLIK.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. LIK.DE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so LIK is creating value.
  • LIK has about the same amout of shares outstanding than it did 1 year ago.
  • LIK has about the same amout of shares outstanding than it did 5 years ago.
  • LIK has a better debt/assets ratio than last year.
LIK.DE Yearly Shares OutstandingLIK.DE Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 50K 100K 150K 200K 250K
LIK.DE Yearly Total Debt VS Total AssetsLIK.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • An Altman-Z score of 6.28 indicates that LIK is not in any danger for bankruptcy at the moment.
  • LIK's Altman-Z score of 6.28 is amongst the best of the industry. LIK outperforms 100.00% of its industry peers.
  • A Debt/Equity ratio of 0.56 indicates that LIK is somewhat dependend on debt financing.
  • With an excellent Debt to Equity ratio value of 0.56, LIK belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF N/A
Altman-Z 6.28
ROIC/WACC2.13
WACC7.15%
LIK.DE Yearly LT Debt VS Equity VS FCFLIK.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

  • LIK has a Current Ratio of 3.25. This indicates that LIK is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 3.25, LIK belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • LIK has a Quick Ratio of 3.23. This indicates that LIK is financially healthy and has no problem in meeting its short term obligations.
  • LIK's Quick ratio of 3.23 is amongst the best of the industry. LIK outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.25
Quick Ratio 3.23
LIK.DE Yearly Current Assets VS Current LiabilitesLIK.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. LIK.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 6.76% over the past year.
  • Measured over the past years, LIK shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.60% on average per year.
  • The Revenue has decreased by -0.13% in the past year.
  • Measured over the past years, LIK shows a very strong growth in Revenue. The Revenue has been growing by 35.58% on average per year.
EPS 1Y (TTM)6.76%
EPS 3Y-7.6%
EPS 5YN/A
EPS Q2Q%81.09%
Revenue 1Y (TTM)-0.13%
Revenue growth 3Y14.74%
Revenue growth 5Y35.58%
Sales Q2Q%23.74%

3.2 Future

  • LIK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 36.66% yearly.
  • LIK is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.19% yearly.
EPS Next Y9.79%
EPS Next 2Y33.32%
EPS Next 3Y36.66%
EPS Next 5YN/A
Revenue Next Year22.17%
Revenue Next 2Y24.43%
Revenue Next 3Y22.19%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
LIK.DE Yearly Revenue VS EstimatesLIK.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M
LIK.DE Yearly EPS VS EstimatesLIK.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2024 2025 2026 2027 0 10 20 30 40

More info and screens

Find the best growth stocksShow best growing peers

2

4. LIK.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 31.27, the valuation of LIK can be described as expensive.
  • Compared to the rest of the industry, the Price/Earnings ratio of LIK indicates a slightly more expensive valuation: LIK is more expensive than 70.37% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of LIK to the average of the S&P500 Index (25.61), we can say LIK is valued slightly more expensively.
  • A Price/Forward Earnings ratio of 15.56 indicates a correct valuation of LIK.
  • LIK's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. LIK is more expensive than 66.67% of the companies in the same industry.
  • LIK's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.79.
Industry RankSector Rank
PE 31.27
Fwd PE 15.56
LIK.DE Price Earnings VS Forward Price EarningsLIK.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • LIK's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. LIK is more expensive than 74.07% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.71
LIK.DE Per share dataLIK.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates LIK does not grow enough to justify the current Price/Earnings ratio.
  • The decent profitability rating of LIK may justify a higher PE ratio.
  • A more expensive valuation may be justified as LIK's earnings are expected to grow with 36.66% in the coming years.
PEG (NY)3.19
PEG (5Y)N/A
EPS Next 2Y33.32%
EPS Next 3Y36.66%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. LIK.DE Dividend Analysis

5.1 Amount

  • LIK does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

LIK.DE Fundamentals: All Metrics, Ratios and Statistics

LIMES SCHLOSSKLINIKEN AG

FRA:LIK (3/25/2026, 7:00:00 PM)

490

-10 (-2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)09-03
Earnings (Next)N/A
Inst Owners6.91%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap142.10M
Revenue(TTM)42.54M
Net Income(TTM)4.60M
Analysts80
Price Target724.2 (47.8%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)18.33%
PT rev (3m)18.33%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)7.27%
Revenue NY rev (3m)7.27%
Valuation
Industry RankSector Rank
PE 31.27
Fwd PE 15.56
P/S 3.34
P/FCF N/A
P/OCF N/A
P/B 6.44
P/tB 10.11
EV/EBITDA 14.71
EPS(TTM)15.67
EY3.2%
EPS(NY)31.49
Fwd EY6.43%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS146.68
BVpS76.04
TBVpS48.46
PEG (NY)3.19
PEG (5Y)N/A
Graham Number163.73
Profitability
Industry RankSector Rank
ROA 10.51%
ROE 20.85%
ROCE 18.69%
ROIC 15.26%
ROICexc 21.72%
ROICexgc 31.24%
OM 16.42%
PM (TTM) 10.81%
GM 95.03%
FCFM N/A
ROA(3y)11.35%
ROA(5y)9.91%
ROE(3y)25.76%
ROE(5y)22.78%
ROIC(3y)15.32%
ROIC(5y)N/A
ROICexc(3y)23.25%
ROICexc(5y)N/A
ROICexgc(3y)57.5%
ROICexgc(5y)N/A
ROCE(3y)18.77%
ROCE(5y)N/A
ROICexgc growth 3Y-31.59%
ROICexgc growth 5YN/A
ROICexc growth 3Y-14.79%
ROICexc growth 5YN/A
OM growth 3Y-14.42%
OM growth 5YN/A
PM growth 3Y-19.47%
PM growth 5YN/A
GM growth 3Y-0.09%
GM growth 5Y-0.06%
F-ScoreN/A
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF N/A
Debt/EBITDA 1.26
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.25
Quick Ratio 3.23
Altman-Z 6.28
F-ScoreN/A
WACC7.15%
ROIC/WACC2.13
Cap/Depr(3y)160.08%
Cap/Depr(5y)N/A
Cap/Sales(3y)11.64%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.76%
EPS 3Y-7.6%
EPS 5YN/A
EPS Q2Q%81.09%
EPS Next Y9.79%
EPS Next 2Y33.32%
EPS Next 3Y36.66%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.13%
Revenue growth 3Y14.74%
Revenue growth 5Y35.58%
Sales Q2Q%23.74%
Revenue Next Year22.17%
Revenue Next 2Y24.43%
Revenue Next 3Y22.19%
Revenue Next 5YN/A
EBIT growth 1Y28.44%
EBIT growth 3Y-1.81%
EBIT growth 5YN/A
EBIT Next Year83.06%
EBIT Next 3Y50.22%
EBIT Next 5Y29.34%
FCF growth 1Y890.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y18.63%
OCF growth 3YN/A
OCF growth 5YN/A

LIMES SCHLOSSKLINIKEN AG / LIK.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of LIMES SCHLOSSKLINIKEN AG (LIK.DE) stock?

ChartMill assigns a fundamental rating of 6 / 10 to LIK.DE.


What is the valuation status for LIK stock?

ChartMill assigns a valuation rating of 2 / 10 to LIMES SCHLOSSKLINIKEN AG (LIK.DE). This can be considered as Overvalued.


How profitable is LIMES SCHLOSSKLINIKEN AG (LIK.DE) stock?

LIMES SCHLOSSKLINIKEN AG (LIK.DE) has a profitability rating of 7 / 10.


What is the valuation of LIMES SCHLOSSKLINIKEN AG based on its PE and PB ratios?

The Price/Earnings (PE) ratio for LIMES SCHLOSSKLINIKEN AG (LIK.DE) is 31.27 and the Price/Book (PB) ratio is 6.44.